دورموسيدان جل
Dormosedan Gel (detomidine hydrochloride) is an alpha-2 adrenoceptor agonist formulated as an oral transmucosal gel for mild standing sedation and restraint in horses to facilitate non-painful husbandry and minor veterinary procedures.
الشكل الصيدلاني
Gel
نوع المنتج
دواء
الشركة المصنعة
الحجم
3.0 mL prefilled oral dial-a-dose syringe containing 7.6 mg/mL detomidine hydrochloride
| النوع الحيواني | الجرعة | طريقة الإعطاء | المدة |
|---|---|---|---|
| Horse | 0.040 mg/kg (0.012 mL/kg) body weight sublingually | Oral transmucosal (Sublingual) | Single dose; provides sedation lasting 90 to 180 minutes |
| النوع الحيواني | اللحم (أيام) | الحليب (أيام) | البيض (أيام) |
|---|---|---|---|
| Horse | 3 |
Mild standing sedation and restraint to facilitate non-painful minor veterinary, dental, and husbandry procedures (such as shoeing, clipping, floating teeth, and clinical examinations) in horses.
Do not use in horses with preexisting severe cardiovascular disease, heart block, or bradycardia.
Do not use in horses with severe respiratory disorders or acute hepatic/renal failure.
Do not administer concurrently with intravenous potentiated sulfonamides.
Sedated horses may appear completely asleep but retain response to sudden loud noises and defensive kicking.
Food and water should be withheld until sedation has completely dissipated to prevent esophageal choke or colic.
Impermeable gloves must be worn during administration to prevent human accidental dermal absorption.
Bradycardia, transient ataxia, penile relaxation/prolapse, mild sweating, muscle tremors, and transient hypertension followed by hypotension.
Dormosedan Gel Prescribing Information
نشرةلا توجد أمراض مرتبطة.
لا توجد بيانات
لم تتم إضافة المعلومات بعد.
شركة مصنعة
لا توجد بدائل متاحة.